Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report

Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report

Abstract Background Methotrexate (MTX) is a frequently used drug in the treatment of rheumatoid arthritis (RA), but occurrences of lymphoproliferative disorders (LPD) have been reported in patients undergoing an MTX regimen. Almost half of the patients with methotrexate-associated lymphoproliferativ...

Full description

Bibliographic Details
Main Authors: Masahiro Nomura, Ryusuke Sumiya, Hayato Ono, Takeshi Nagai, Keigo Kumazawa, Atsushi Shimizu, Daisuke Endo, Nobuyoshi Aoyanagi
Format: Article
Language:English
Published: BMC 2021-01-01
Series:World Journal of Surgical Oncology
Subjects:
Methotrexate
Lymphoproliferative disorder
Intestinal perforation
Jejunum
Epstein–Barr virus
Case report
Online Access:https://doi.org/10.1186/s12957-020-02114-0

Internet

https://doi.org/10.1186/s12957-020-02114-0

Similar Items